Treatment of postpartum depression, Part 1: A critical review of biological interventions

Journal of Clinical Psychiatry

Volumn 65, Issue 9, 2004, Pages 1242-1251

  Dennis, Cindy Lee E ^a   Stewart, Donna E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESTRADIOL; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITALIZATION; HUMAN; MULTIMODALITY CANCER THERAPY; PHOTOTHERAPY; PREGNANCY; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SLEEP DEPRIVATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION, POSTPARTUM; ELECTROCONVULSIVE THERAPY; ESTRADIOL; FEMALE; HUMANS; PHOTOTHERAPY; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SLEEP DEPRIVATION; TREATMENT OUTCOME;

EID: 5444265659     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0914     Document Type: Review

References (131)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105 (Pubitemid 37432885)
2. O'Hara MW, Schlechte JA, Lewis DA, et al. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol 1991;100:63-73
3. Kendell RE. Diagnosis and classification of functional psychoses. Br Med Bull 1987;43:499-513 (Pubitemid 17097033)
4. Paffenbarger RS. Epidemiological aspects of mental illness associated with childbearing. In: Brockington I, Kumar R, eds. Motherhood and Mental Illness. London, England: Academic Press; 1982:21-36
5. Stocky A, Lynch J. Acute psychiatric disturbance in pregnancy and the puerperium. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:73-87 (Pubitemid 30153871)
6. Evins GG, Theofrastous JP. Postpartum depression: a review of postpartum screening. Prim Care Update for Ob Gyns 1997;4:241-246 (Pubitemid 27500548)
7. Affonso DD, De AK, Horowitz JA, et al. An international study exploring levels of postpartum depressive symptomatology. J Psychosom Res 2000;49:207-216 (Pubitemid 32010877)
8. Canadian Task Force on Preventive Health Care. The Canadian Guide to Clinical Preventive Health Care. Ottawa, Ontario, Canada: Canadian Task Force on Preventive Health Care; 2003
9. Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 2002;167:1253-1260 (Pubitemid 35370644)
10. Wisner KL, Parry BL, Piontek CM. Postpartum depression. N Engl J Med 2002:347:194-199 (Pubitemid 34764824)
11. Nonacs R, Cohen LS. Depression during pregnancy: diagnosis and treatment options. J Clin Psychiatry 2002;63(suppl 7):24-30 (Pubitemid 34454036)
12. Marcus SM, Barry KL, Flynn HA, et al. Treatment guidelines for depression in pregnancy. Int J Gynaecol Obstet 2001;72:61-70 (Pubitemid 32007866)
13. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 1997;314:932-936 (Pubitemid 27140217)
14. Hoffbrand S, Howard L, Crawley H. Antidepressant drug treatment for postnatal depression. Cochrane Database of Syst Rev 2001(2):CD002018
15. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-786 (Pubitemid 17082036)
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatiy 1960;23:56-62
17. Stowe ZN, Casarella J, Landry J, et al. Sertraline in the treatment of women with postpartum major depression. Depression 1995;3:49-55
18. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988;45:742-747 (Pubitemid 18189914)
19. Suri R, Burt VK, Altshuler LL, et al. Fluvoxamine for postpartum depression [letter]. Am J Psychiatry 2001;158:1739-1740
20. Cohen LS, Viguera AC, Bouffard SM, et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 2001;62:592-596 (Pubitemid 32848161)
21. Hendrick V, Altshuler L, Strouse T, et al. Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety 2000;11:66-72 (Pubitemid 30228412)
22. Newport DJ, Hostetter A, Arnold A, et al. The treatment of postpartum depression: minimizing infant exposures. J Clin Psychiatiy 2002;63 (suppl 7):31-44 (Pubitemid 34454037)
23. Newport DJ, Wilcox MM, Stowe ZN. Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Semin Perinatol 2001;25:177-190 (Pubitemid 32567510)
24. Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry 1998;59(suppl 2):34-40 (Pubitemid 28155487)
25. Misri S, Kostaras D, Kostaras X. The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge. Can J Psychiatry 2000;45:285-287 (Pubitemid 30345851)
26. Misri S, Kostaras X. Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Saf 2002;25:903-911 (Pubitemid 35252716)
27. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatiy 1996;153:1132-1137 (Pubitemid 26299830)
28. Wisner KL, Gelenberg AJ, Leonard H, et al. Pharmacologic treatment of depression during pregnancy. JAMA 1999;282:1264-1269 (Pubitemid 29468499)
29. Altshuler LL, Cohen LS, Moline ML, et al. The Expert Consensus Guideline Series. Treatment of Depression in Women. Postgrad Med 2001(Spec No):1-107
30. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001;158:1631-1637 (Pubitemid 32923655)
31. Ward RK, Zamorski MA. Benefits and risks of psychiatric medications during pregnancy. Am Fam Physician 2002;66:629-636 (Pubitemid 34920198)
32. Llewellyn A, Stowe ZN. Psychotropic medications in lactation. J Clin Psychiatry 1998;59(suppl 2):41-52 (Pubitemid 28155488)
33. Yoshida K, Smith B, Kumar R. Psychotropic drags in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. J Psychopharmacol (Oxf) 1999;13:64-80 (Pubitemid 29141277)
34. Arnon J, Shechtman S, Ornoy A. The use of psychiatric drugs in pregnancy and lactation. Isr J Psychiatry Relat Sci 2000;37:205-222
35. Chisholm CA, Kuller JA. A guide to the safety of CNS-active agents during breastfeeding. Drug Saf 1997;17:127-142 (Pubitemid 27395578)
36. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994;8:461-475
37. Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 2002;53:39-49 (Pubitemid 34038614)
38. Stewart DE. Women and selective serotonin receptor inhibitor antidepressants in the real world [editorial]. Medscape Womens Health 2001;6:1
39. Wisner KL, Zarin DA, Holmboe ES, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000;157:1933-1940
40. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-933 (Pubitemid 26102548)
41. Ahokas A, Kaukoranta J, Aito M. Effect of oestradiol on postpartum depression. Psychopharmacology (Berl) 1999;146:108-110 (Pubitemid 29441121)
42. Ahokas A, Kaukoranta J, Wahlbeck K, et al. Estrogen deficiency in severe postpartum depression: successful treatment with subungual physiologic 17b-estradiol: a preliminary study. J Clin Psychiatry 2001;62:332-336 (Pubitemid 32545553)
43. Gillin JC. The sleep therapies of depression. Prog Neuropsychopharmacol Biol Psychiatry 1983;7:351-364
44. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990;147:14-21 (Pubitemid 20025501)
45. Sack DA, Duncan W, Rosenthal NE, et al. The timing and duration of sleep in partial sleep deprivation therapy of depression. Acta Psychiatr Scand 1988;77:219-224 (Pubitemid 18073214)
46. Kuhs H, Tolle R. Sleep deprivation therapy. Biol Psychiatry 1991;29:1129-1148
47. Leibenluft E, Moul DE, Schwartz PJ, et al. A clinical trial of sleep deprivation in combination with antidepressant medication. Psychiatry Res 1993;46:213-227 (Pubitemid 23121523)
48. Parry BL, Curran ML, Stuenkel CA, et al. Can critically timed sleep deprivation be useful in pregnancy and postpartum depressions? J Affect Disord 2000;60:201-212
49. Corral M, Kuan A, Kostaras D. Blight light therapy's effect on postpartum depression [letter]. Am J Psychiatry 2000;157:303-304 (Pubitemid 30080919)
50. Oren DA, Wisner KL, Spinelli M, et al. An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry 2002;159:666-669 (Pubitemid 34274954)
51. Bhatia SC, Baldwin SA, Bhatia SK. Electroconvulsive therapy during the third trimester of pregnancy. J ECT 1999;15:270-274
52. Dorn JB. Electroconvulsive therapy with fetal monitoring in a bipolar pregnant patient. Convuls Ther 1985;1:217-221 (Pubitemid 15235388)
53. Livingston JC, Johnstone WM Jr, Hadi HA. Electroconvulsive therapy in a twin pregnancy: a case report. Am J Perinatol 1994;11:116-118 (Pubitemid 24109167)
54. Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 2001;46:710-719 (Pubitemid 33127086)
55. Walker R, Swartz CM. Electroconvulsive therapy during high-risk pregnancy. Gen Hosp Psychiatry 1994;16:348-353 (Pubitemid 24267531)
56. Yellowlees PM, Page T. Safe use of electroconvulsive therapy in pregnancy. Med J Aust 1990;153:679-680
57. Whitton A, Appleby L, Warner R. Maternal thinking and the treatment of postnatal depression. Int Rev Psychiatry 1996;8:73-78 (Pubitemid 26179250)
58. Jermain DM. Treatment of postpartum depression. Am Pharm 1995;NS35:33-38
59. Dijk DJ, Czeisler CA. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 1995;15:3526-3538
60. Breyer-Pfaff U, Nill K, Entenmann KN, et al. Secretion of amitriptyline and metabolites into breast milk [letter]. Am J Psychiatry 1995;152:812-813
61. Pittard WB, O'Neal W. Amitriptyline excretion in human milk [letter]. J Clin Psychopharmacol 1986;6:383-384
62. Brixen-Rasmussen L, Halgrener J, Jorgensen A. Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology (Berl) 1982;76:94-95 (Pubitemid 12187373)
63. Bader TF, Newman K. Amitriptyline in human breast milk and the nursing infant's serum. Am J Psychiatry 1980;137:855-856 (Pubitemid 10085134)
64. Schimmell MS, Katz EZ, Shaag Y, et al. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 1991;29:479-484
65. Stancer HC, Reed KL. Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum. Am J Psychiatry 1986;143:1597-1600 (Pubitemid 17196207)
66. Sovner R, Orsulak PJ. Excretion of imipramine and desipramine in human breast milk. Am J Psychiatry 1979;136:451-452 (Pubitemid 9147456)
67. Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;33:690-693 (Pubitemid 29309726)
68. Kemp J, Ilett KF, Booth J, et al. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985;20:497-499 (Pubitemid 16230373)
69. Weinstock L, Cohen LS, Bailey JW, et al. Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom 2001;70:158-162 (Pubitemid 32429718)
70. Ware MR, DeVane CL. Imipramine treatment of panic disorder during pregnancy. J Clin Psychiatry 1990;51:482-484
71. Altshuler LL, Burt VK, McMullen M, et al. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995;56:243-245
72. Matheson I, Skjaeraasen J. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients. Eur J Clin Pharmacol 1988;35:217-220 (Pubitemid 18223138)
73. Wisner KL, Perel JM, Findling RL, et al. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull 1997;33:249-251 (Pubitemid 27293115)
74. Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991;148:1234-1236
75. Rampono J, Kristensen JH, Hackett LP, et al. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br J Clin Pharmacol 2000;50:263-268 (Pubitemid 30701422)
76. Schmidt K, Olesen OV, Jensen PN. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000;47:164-165 (Pubitemid 30069742)
77. Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72:184-191 (Pubitemid 35034496)
78. Spigset O, Carieborg L, Ohman R, et al. Excretion of citalopram in breast milk. Br J Clin Pharmacol 1997;44:295-298 (Pubitemid 27376260)
79. Suri R, Stowe ZN, Hendrick V, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol Psychiatry 2002;52:446-451 (Pubitemid 35266736)
80. Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr (Phila) 2001;40:681-684
81. Hendrick V, Stowe ZN, Altshuler LL, et al. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry 2001;50:775-782
82. Kristensen JH, Ilett KF, Hackett LP, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999;48:521-527 (Pubitemid 29454232)
83. Yoshida K, Smith B, Craggs M, et al. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998;172:175-178 (Pubitemid 28097718)
84. Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila) 1998;37:41-114 (Pubitemid 28065100)
85. Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 1992;89:676-677
86. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine [abstract]. Pediatrics 1999;104:e61
87. Cohen LS, Heller VL, Bailey JW, et al. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatiy 2000;48:996-1000 (Pubitemid 30811905)
88. Goldstein DJ, Corbin LA, Sundell KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997;89:713-718 (Pubitemid 27184852)
89. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993;32:1253-1255 (Pubitemid 23319187)
90. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996;36:42-47 (Pubitemid 26058809)
91. Roy A, Cole K, Goldman Z, et al. Fluoxetine treatment of postpartum depression [letter]. Am J Psychiatry 1993;150:1273 (Pubitemid 23218922)
92. Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series [abstract]. Pediatrics 1999;104:e11
93. Piontek CM, Wisner KL, Perel JM, et al. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001;62:111-113 (Pubitemid 32199867)
94. Arnold LM, Suckow RF, Lichtenstein PK. Fluvoxamine concentrations in breast milk and in maternal and infant sera. J Clin Psychopharmacol 2000;20:491-493 (Pubitemid 30463770)
95. Hagg S, Granberg K, Carleborg L. Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol 2000;49:286-288 (Pubitemid 30150994)
96. Hendrick V, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001;179:163-166 (Pubitemid 32756499)
97. Kristensen JH, Hackett LP, Kohan R, et al. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J Hum Lact 2002;18:139-143
98. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk [letter]. Br J Clin Pharmacol 1991;31:209
99. Yoshida K, Smith B, Kumar RC. Fluvoxamine in breast-milk and infant development [letter]. Br J Clin Pharmacol 1997;44:210-211 (Pubitemid 27327082)
100. Ohman R, Hagg S, Carleborg L, et al. Excretion of paroxetine into breast milk. J Clin Psychiatiy 1999;60:519-523 (Pubitemid 29413471)
101. Begg EJ, Duffull SB, Saunders DA, et al. Paroxetine in human milk. Br J Clin Pharmacol 1999;48:142-147 (Pubitemid 29349448)
102. Hendrick V, Stowe ZN, Altshuler LL, et al. Paroxetine use during breast-feeding. J Clin Psychopharmacol 2000;20:587-589
103. Misri S, Kim J, Riggs KW, et al. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 2000;61:828-832 (Pubitemid 30947796)
104. Spigset O, Carleborg L, Norstrom A, et al. Paroxetine level in breast milk [letter]. J Clin Psychiatry 1996;57:39 (Pubitemid 26030527)
105. Stowe ZN, Cohen LS, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry 2000;157:185-189 (Pubitemid 30080896)
106. Wisner KL, Findling RL, Perel JM. Paroxetine in breast milk [letter]. Am J Psychiatry 2001;158:144-145
107. Dodd S, Stocky A, Buist A, et al. Sertraline in paired blood plasma and breast-milk samples from nursing mothers. Hum Psychopharmacol 2000;15:161-264 (Pubitemid 30394357)
108. Dodd S, Stocky A, Buist A, et al. Sertraline analysis in the plasma of breast-fed infants. Aust N Z J Psychiatry 2001;35:545-546 (Pubitemid 32798779)
109. Epperson CN, Anderson GM, McDougle CJ. Sertraline and breast-feeding [letter]. N Engl J Med 1997;336:1189-1190
110. Holland D. An observation of the effect of sertraline on breast milk supply [letter]. Aust N Z J Psychiatry 2000;34:1032
111. Hostetter A, Stowe ZN, Strader JR Jr, et al. Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depress Anxiety 2000;11:51-57 (Pubitemid 30228410)
112. Kristensen JH, Ilett KF, Dusci LJ, et al. Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol 1998;45:453-1157 (Pubitemid 28227346)
113. Oca MJ, Donn SM. Association of maternal sertraline (Zoloft) therapy and transient neonatal nystagmus. J Perinatol 1999;19:460-461
114. Stowe ZN, Owens MJ, Landry JC, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997;154:1255-1260 (Pubitemid 27369177)
115. Rybakowski JK. Moclobemide in pregnancy. Pharmacopsychiatry 2001;34:82-83 (Pubitemid 32221754)
116. Mayersohn M, Guentert TW. Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide. Clin Pharmacokinet 1995;29:292-332
117. Goodnick PJ. Pharmacokinetic optimisation of therapy with newer antidepressants. Clin Pharmacokinet 1994;27:307-330 (Pubitemid 24315089)
118. Pons G, Schoerlin MP, Tam YK, et al. Moclobemide excretion in human breast milk. Br J Clin Pharmacol 1990;29:27-31 (Pubitemid 20130548)
119. Gracious BL, Wisner KL. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations. Depress Anxiety 1997;6:124-128 (Pubitemid 28079900)
120. Lindberg C, Boreus LO, de Chateau P, et al. Transfer of terbutaline into breast milk. Eur J Respir Dis Suppl 1984;134:87-91 (Pubitemid 14138742)
121. Boreus LO, de Chateau PU. Terbutaline in breast milk [letter]. Br J Clin Pharmacol 1982;13:731-732
122. Lonnerholm G, Lindstrom B. Terbutaline excretion into breast milk. Br J Clin Pharmacol 1982;13:729-730 (Pubitemid 13139892)
123. Gelenberg AJ. Single case study: amoxapine, a new antidepressant, appears in human milk. J Nerv Ment Dis 1979;167:635-636
124. Briggs GG, Samson JH, Ambrose PJ, et al. Excretion of bupropion in breast milk. Ann Pharmacother 1993;27:431-433 (Pubitemid 23123890)
125. Yapp P, Ilett KF, Kristensen JH, et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 2000;34:1269-1272 (Pubitemid 30822560)
126. Dodd S, Maguire KP, Burrows GD, et al. Nefazodone in the breast milk of nursing mothers: a report of two patients [letter]. J Clin Psychopharmacol 2000;20:717-718 (Pubitemid 30953824)
127. Verbeeck RK, Ross SG, McKenna EA. Excretion of trazodone in breast milk. Br J Clin Pharmacol 1986;22:367-370 (Pubitemid 17170731)
128. Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002;53:17-22 (Pubitemid 34117734)
129. Hendrick V, Altshuler L, Wertheimer A, et al. Venlafaxine and breastfeeding [letter]. Am J Psychiatry 2001;158:2089-2090
130. Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 1998;45:459-462 (Pubitemid 28227347)
131. Klier CM, Schafer MR, Schmid-Siegel B, et al. St. John's wort (Hypericum perforatum): is it safe during breastfeeding? Pharmacopsychiatry 2002;35:29-30